Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04533815 · ClinicalTrials.gov registry record · NA
Enhancing Sleep Quality for Nursing Home Residents With Dementia
A NA study, sponsored by University of Alabama, Tuscaloosa.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT04533815: Completed NA study, sponsored by University of Alabama, Tuscaloosa.
NCT04533815 is a NA study that has completed, run by University of Alabama, Tuscaloosa. The registered enrollment target is 23 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04533815, a NA study, has completed, sponsored by University of Alabama, Tuscaloosa.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
This was a pilot study (R61) to prepare for a full clinical trial (R33) aiming to improve clinical outcomes for an important, growing, and vulnerable population-nursing home (NH) residents with Alzheimer's disease or related dementias (ADRDs). The goal was to pilot and refine the research methods and intervention that would be subsequently evaluated in a full implementation trial (hybrid type III). The goal of the evidence-based intervention (LOCK) that was refined in this pilot study and will be evaluated in the subsequent full clinical trial is to improve the sleep of NH residents with ADRD.
Primary Outcome
Total sleep time (total minutes asleep each nighttime period - 7pm to 7am)
Interventions
- BEHAVIORAL LOCK sleep intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2021-05-05 |
| Est. Completion | 2022-08-31 |
| Phase | NA |
What the finished NCT04533815 record still lists
NCT04533815 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which LOCK sleep intervention is the first listed.
NCT04533815 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04533815 about?
NCT04533815 is a clinical study titled "Enhancing Sleep Quality for Nursing Home Residents With Dementia". This was a pilot study (R61) to prepare for a full clinical trial (R33) aiming to improve clinical outcomes for an important, growing, and vulnerable population-nursing home (NH) residents with Alzheimer's disease or related dementias (ADRDs). The goal was to pilot and refine the research methods an...
What is the current status of trial NCT04533815?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2021-05-05. Estimated completion is 2022-08-31.
What interventions are being tested in trial NCT04533815?
The interventions under investigation include: LOCK sleep intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04533815?
This trial is sponsored by University of Alabama, Tuscaloosa, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04533815's enrollment target sits among peer trials
23 1755th of 2000 higher than 245 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI